SYSTEMIC MASTOCYTOSIS
Clinical trials for SYSTEMIC MASTOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC MASTOCYTOSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC MASTOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a bone drug stop fractures in rare mast cell disease?
Disease control CompletedThis study tested whether denosumab, a drug given as a shot every 6 months, can improve bone density and prevent fractures in people with osteoporosis caused by systemic mastocytosis. The trial enrolled 24 adults with indolent systemic or cutaneous mastocytosis and osteoporosis. …
Matched conditions: SYSTEMIC MASTOCYTOSIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 12:00 UTC
-
New antibody drug shows promise for tough blood cancers
Disease control CompletedThis early-stage trial tested a drug called flotetuzumab in 13 people with advanced blood cancers that had returned or stopped responding to treatment. The goal was to find the best dose and check for side effects. Flotetuzumab is a lab-made antibody that may stop cancer cells fr…
Matched conditions: SYSTEMIC MASTOCYTOSIS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC